Genscript Biotech Corporation (1548.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Genscript Biotech Corporation, with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -6.38x |
| P/B Ratio | 0.87x |
| P/S Ratio | 3.60x |
| Profitability | |
| Gross Margin | 57.7% |
| Operating Margin | 26.6% |
| Net Margin | -55.5% |
| EBITDA Margin | 33.1% |
| Liquidity | |
| Current Ratio | 1.47x |
| Quick Ratio | 1.41x |
| Leverage | |
| Debt/Equity | 0.07x |
YoY = year-over-year change. Source: FMP..